NCT03579875: Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
- State
- Under way
- Phase
- Phase 2
- People
- 48 planned
- Started
- 13 Nov 2018
- Primary completion
- 1 Jan 2027
- Arms
- Treatment Plan 2: CY, FLU, MP, Rituximab in patients with Fanconi Anemia
- Results
- None posted
- 9 Jul 2018: Trial registered
- 13 Nov 2018: Trial started